Nasopharyngeal Testing among Healthcare Workers (HCWs) of a Large University Hospital in Milan, Italy during Two Epidemic Waves of COVID-19.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 08 2021
Historique:
received: 25 06 2021
revised: 17 08 2021
accepted: 17 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 1 9 2021
Statut: epublish

Résumé

since October 2020, a second SARS-CoV-2 epidemic wave has hit Italy. We investigate the frequency of positive nasopharyngeal swabs among HCWs during the two waves and the association with occupation and demographic characteristics. this is a retrospective, observational study conducted in a large university hospital in Milan, Northern Italy. We defined two epidemic waves: 1st (February 2020-July 2020) and 2nd (August 2020-January 2021). Occupational and demographic characteristics of HCWs who underwent nasopharyngeal swabs for SARS-CoV-2 were collected. in the 1st wave, 242 positive subjects (7.2%) were found among 3378 HCWs, whereas in the 2nd wave, the positive subjects were 545 out of 4465 (12.2%). In both epidemic waves positive NPSs were more frequent among HCWs with health-related tasks and lower among students ( during the 2nd epidemic wave, we confirmed a significant impact of COVID-19 among HCWs. The rise of infection rate among HCWs seems to reflect the increasing spread of SARS-CoV-2 among the overall population.

Sections du résumé

BACKGROUND
since October 2020, a second SARS-CoV-2 epidemic wave has hit Italy. We investigate the frequency of positive nasopharyngeal swabs among HCWs during the two waves and the association with occupation and demographic characteristics.
METHODS
this is a retrospective, observational study conducted in a large university hospital in Milan, Northern Italy. We defined two epidemic waves: 1st (February 2020-July 2020) and 2nd (August 2020-January 2021). Occupational and demographic characteristics of HCWs who underwent nasopharyngeal swabs for SARS-CoV-2 were collected.
RESULTS
in the 1st wave, 242 positive subjects (7.2%) were found among 3378 HCWs, whereas in the 2nd wave, the positive subjects were 545 out of 4465 (12.2%). In both epidemic waves positive NPSs were more frequent among HCWs with health-related tasks and lower among students (
CONCLUSIONS
during the 2nd epidemic wave, we confirmed a significant impact of COVID-19 among HCWs. The rise of infection rate among HCWs seems to reflect the increasing spread of SARS-CoV-2 among the overall population.

Identifiants

pubmed: 34444497
pii: ijerph18168748
doi: 10.3390/ijerph18168748
pmc: PMC8392643
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Commun. 2020 Jul 8;11(1):3500
pubmed: 32641730
BMJ Open. 2021 Feb 22;11(2):e047216
pubmed: 33619203
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Acta Biomed. 2020 Sep 07;91(3):e2020016
pubmed: 32921712
Sci Rep. 2021 Jun 10;11(1):12312
pubmed: 34112899
Occup Environ Med. 2021 Feb 4;:
pubmed: 33542096
Elife. 2020 May 11;9:
pubmed: 32392129
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214
pubmed: 32746953
Nat Commun. 2021 Feb 15;12(1):1018
pubmed: 33589636
Lancet. 2021 Mar 27;397(10280):1204-1212
pubmed: 33743221
Lancet Infect Dis. 2021 Jan;21(1):23-24
pubmed: 32437699
JAMA Intern Med. 2021 May 1;181(5):672-679
pubmed: 33625463
Occup Environ Med. 2020 Dec 4;:
pubmed: 33277384
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Nat Commun. 2021 Feb 9;12(1):897
pubmed: 33563974
Int J Infect Dis. 2021 Jan;102:299-302
pubmed: 33130202
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
EClinicalMedicine. 2021 May;35:100861
pubmed: 33937733
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Int J Environ Res Public Health. 2020 Jun 19;17(12):
pubmed: 32575505
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Microorganisms. 2021 Feb 25;9(3):
pubmed: 33669151
EBioMedicine. 2020 Nov;61:103069
pubmed: 33130396

Auteurs

Agnese Comelli (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Dario Consonni (D)

Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Andrea Lombardi (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.

Giulia Viero (G)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Massimo Oggioni (M)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Patrizia Bono (P)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Sara Colonia Uceda Renteria (SC)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Ferruccio Ceriotti (F)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Davide Mangioni (D)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Antonio Muscatello (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Alessandra Piatti (A)

Medical Direction, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Angela Cecilia Pesatori (AC)

Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.

Silvana Castaldi (S)

Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy.
Quality Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Luciano Riboldi (L)

Occupational Health Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Alessandra Bandera (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, 20122 Milan, Italy.

Andrea Gori (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, 20122 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH